← Eichor
Study identifier: NCT03452202 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Using tDCS in Speech-based Stroke Rehabilitation

Condition: Apraxia of Speech  ·  Sponsor: NYU Langone Health

PhaseNA
Planned participants24
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

This description comes directly from the study's public registry record.

Talk to the study team

Buchwald Lab  ·  buchwald-lab@nyu.edu

Always discuss trial participation with your own doctor first.

Locations (2)

New York University School of MedicineNew York, New York, United StatesRecruiting
Burke Rehabilitation HospitalWhite Plains, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03452202